Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

BACKGROUND: Hepatocellular carcinoma (HCC) is a malignant tumor with great variation in prognosis among individuals. Changes in metabolism influence disease progression and clinical outcomes. The objective of this study was to determine the overall survival (OS) risk of HCC patients from a metabolic...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Hepatocell Carcinoma
Autori principali: Weng, Jialei, Zhou, Chenhao, Zhou, Qiang, Chen, Wanyong, Yin, Yirui, Atyah, Manar, Dong, Qiongzhu, Shi, Yi, Ren, Ning
Natura: Artigo
Lingua:Inglês
Pubblicazione: Dove 2021
Soggetti:
Original Research
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8018394/
https://ncbi.nlm.nih.gov/pubmed/33824863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JHC.S300633
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi